Batten Disease Treatment Market Continues to Expand as Abeona Therapeutics Inc. partners with Taysha Gene Therapies to boost ABO-202 as potential gene therapy for infantile Batten disease
Batten disease, a rare inherited disorder, characterized by the presence of multiple small lesions in the soft palate and the surrounding mucous membrane. These lesions are called nodes in medical terminology. In some cases, there may be a solitary large node in the soft palate. Batten sufferers usually feel no pain and most cases can go unnoticed. The disorder typically affects men between the ages of thirty to sixty. The prevalence of neurological disorders such as Batten disease, ataxia, Bell’s palsy, epilepsy, and more has increased significantly over the years. As per the National Organization for Rare Disorders (NORD), around 25 to 35 in 100,000 people in the U.S. are affected by Bell’s palsy, while 40,000 individuals are diagnosed with the same in the U.S. each year. As per the World Health Organization (WHO), in June 2019, around 50 million people across the globe had epilepsy, which makes it one of the most common neurological disorders worldwide. Furthermore, as ...